Seres Therapeutics, Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Seres Therapeutics, Inc. has filed 696 SEC EDGAR filings since 09 Jun 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 696 matching filings.

Per page

25

Current page

3

4

4

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A File 005-88909

SCHEDULE 13G/A filing

Filing date: 06 Jun 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-287027

S-8

Filing date: 07 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37465

10-Q

Filing date: 07 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37465

8-K

Filing date: 07 May 2025
Reporting date: 07 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37465

8-K

Filing date: 22 Apr 2025
Reporting date: 21 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37465

8-K

Filing date: 14 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Apr 2025
Reporting date: 10 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-37465

DEFA14A

Filing date: 04 Apr 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEF 14A File 001-37465

DEF 14A

Filing date: 13 Mar 2025
Reporting date: 13 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-285769

S-8

Filing date: 13 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-37465

10-K

Filing date: 13 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37465

8-K

Filing date: 13 Mar 2025
Reporting date: 13 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRE 14A File 001-37465

PRE 14A

Filing date: 03 Mar 2025
Reporting date: 03 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37465

8-K

Filing date: 27 Feb 2025
Reporting date: 22 Feb 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .